Preparation of product registration documentation
Introducing new medicinal products into clinical use requires the submission of an extensive dossier to the Office for Registration of Medicinal Products (URPL), prepared in the standardised Common Technical Document (CTD) format. The documentation includes the following modules: Quality (Module 3), Nonclinical Study Reports (Module 4) and Clinical Study Reports (Module 5). The project will include the physicochemical studies required for this documentation, while the experiments planned under Stages I and II will be described in the section devoted to pharmaceutical development studies (Module 3). Module 4 and part of Module 5 are being prepared on the basis of published literature. The results of the animal studies will be included in Module 4 of the dossier.